tiprankstipranks
Grand Pharmaceutical Group Limited (HK:0512)
:0512
Hong Kong Market
0512
Grand Pharmaceutical Group Limited
RESEARCH TOOLSreports
Want to see HK:0512 full AI Analyst Report?

Grand Pharmaceutical Group Limited (0512) Ratios

4 Followers

Grand Pharmaceutical Group Limited Ratios

HK:0512's free cash flow for Q4 2025 was HK$0.51. For the 2025 fiscal year, HK:0512's free cash flow was decreased by HK$ and operating cash flow was HK$0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.14 1.14 1.22 1.22 1.07
Quick Ratio
 0.93 0.93 1.01 0.98 0.86
Cash Ratio
 0.16 0.16 0.20 0.23 0.22
Solvency Ratio
 0.18 0.18 0.35 0.31 0.30
Operating Cash Flow Ratio
 0.22 0.21 0.29 0.42 0.30
Short-Term Operating Cash Flow Coverage
 0.55 0.53 0.61 1.05 0.59
Net Current Asset Value
HK$ -1.68BHK$ -1.68BHK$ -440.31MHK$ -228.66MHK$ -1.28B
Leverage Ratios
Debt-to-Assets Ratio
 0.17 0.17 0.18 0.15 0.20
Debt-to-Equity Ratio
 0.28 0.28 0.27 0.22 0.32
Debt-to-Capital Ratio
 0.22 0.22 0.21 0.18 0.24
Long-Term Debt-to-Capital Ratio
 0.10 0.10 0.07 0.06 0.08
Financial Leverage Ratio
 1.60 1.60 1.52 1.49 1.58
Debt Service Coverage Ratio
 0.70 0.63 0.91 1.00 0.79
Interest Coverage Ratio
 8.04 9.52 12.05 12.98 18.31
Debt to Market Cap
 0.22 0.17 0.26 0.24 0.27
Interest Debt Per Share
 1.39 1.39 1.32 1.03 1.30
Net Debt to EBITDA
 1.52 1.67 0.92 0.70 0.98
Profitability Margins
Gross Profit Margin
55.20%55.20%57.86%61.96%62.24%
EBIT Margin
14.56%12.58%24.77%24.45%28.22%
EBITDA Margin
19.09%17.32%29.09%28.17%32.35%
Operating Profit Margin
10.63%12.58%18.65%25.29%26.33%
Pretax Profit Margin
12.16%12.16%24.49%22.26%26.32%
Net Profit Margin
10.10%10.10%21.20%17.85%21.75%
Continuous Operations Profit Margin
10.13%10.13%21.18%18.00%21.94%
Net Income Per EBT
83.05%83.05%86.54%80.20%82.62%
EBT Per EBIT
114.45%96.66%131.32%88.02%99.97%
Return on Assets (ROA)
4.57%4.57%9.88%8.35%9.30%
Return on Equity (ROE)
7.26%7.29%14.98%12.40%14.71%
Return on Capital Employed (ROCE)
6.58%7.79%11.79%15.87%15.82%
Return on Invested Capital (ROIC)
4.79%5.67%8.71%11.25%10.95%
Return on Tangible Assets
5.58%5.58%11.66%9.27%10.56%
Earnings Yield
5.76%4.51%14.69%13.40%12.76%
Efficiency Ratios
Receivables Turnover
 2.59 2.59 4.18 4.68 4.33
Payables Turnover
 3.03 3.03 4.03 3.01 4.14
Inventory Turnover
 3.71 3.71 3.58 2.88 2.69
Fixed Asset Turnover
 2.55 2.55 3.04 2.64 2.43
Asset Turnover
 0.45 0.45 0.47 0.47 0.43
Working Capital Turnover Ratio
 10.58 10.06 8.51 12.26 11.63
Cash Conversion Cycle
 118.51 118.51 98.74 83.31 131.51
Days of Sales Outstanding
 140.68 140.68 87.34 78.01 84.24
Days of Inventory Outstanding
 98.44 98.44 101.96 126.54 135.50
Days of Payables Outstanding
 120.61 120.61 90.56 121.23 88.23
Operating Cycle
 239.12 239.12 189.30 204.55 219.74
Cash Flow Ratios
Operating Cash Flow Per Share
 0.45 0.43 0.54 0.69 0.54
Free Cash Flow Per Share
 0.24 0.22 0.36 0.55 0.07
CapEx Per Share
 0.21 0.21 0.18 0.14 0.47
Free Cash Flow to Operating Cash Flow
 0.54 0.52 0.67 0.79 0.13
Dividend Paid and CapEx Coverage Ratio
 0.96 0.92 1.24 2.44 0.93
Capital Expenditure Coverage Ratio
 2.17 2.07 3.05 4.87 1.15
Operating Cash Flow Coverage Ratio
 0.33 0.32 0.43 0.71 0.43
Operating Cash Flow to Sales Ratio
 0.13 0.12 0.16 0.23 0.20
Free Cash Flow Yield
3.94%2.82%7.59%13.74%1.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 17.40 22.15 6.81 7.46 7.84
Price-to-Sales (P/S) Ratio
 1.76 2.24 1.44 1.33 1.70
Price-to-Book (P/B) Ratio
 1.27 1.62 1.02 0.93 1.15
Price-to-Free Cash Flow (P/FCF) Ratio
 25.40 35.50 13.17 7.28 66.29
Price-to-Operating Cash Flow Ratio
 13.70 18.32 8.86 5.79 8.50
Price-to-Earnings Growth (PEG) Ratio
 -0.35 -0.44 0.23 -0.88 -0.59
Price-to-Fair Value
 1.27 1.62 1.02 0.93 1.15
Enterprise Value Multiple
 10.72 14.59 5.88 5.43 6.25
Enterprise Value
 25.09B 31.05B 19.91B 16.10B 19.32B
EV to EBITDA
 10.70 14.59 5.88 5.43 6.25
EV to Sales
 2.04 2.53 1.71 1.53 2.02
EV to Free Cash Flow
 29.54 40.09 15.60 8.35 78.62
EV to Operating Cash Flow
 15.93 20.69 10.49 6.64 10.08
Tangible Book Value Per Share
 3.49 3.49 3.63 3.71 3.25
Shareholders’ Equity Per Share
 4.86 4.86 4.70 4.32 3.99
Tax and Other Ratios
Effective Tax Rate
 0.17 0.17 0.14 0.19 0.17
Revenue Per Share
 3.50 3.51 3.33 3.00 2.70
Net Income Per Share
 0.35 0.35 0.70 0.54 0.59
Tax Burden
 0.83 0.83 0.87 0.80 0.83
Interest Burden
 0.84 0.97 0.99 0.91 0.93
Research & Development to Revenue
 0.04 0.04 0.05 0.05 0.06
SG&A to Revenue
 0.40 0.39 0.40 0.12 0.11
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.27 1.21 0.67 1.29 0.92
Currency in HKD